###### Strengths and limitations of this study

-   Developed and internally validated prognostic models using robust methods.

-   The Ankle Injury Management trial was a pragmatic study to enhance generalisability and had very low levels of missing data and is reflective of data that are or could be routinely collected during acute hospital admission and clinic follow-up.

-   Use of an existing clinical trial dataset for developing the prognostic model restricted the choice of potential prognostic factors to those collected in the trial.

Introduction {#s1}
============

Background {#s1a}
----------

Ankle fractures in older people are increasing in number as the population ages.[@R1] Older people have a worse prognosis than younger adults for recovering function after fractures.[@R2] However, there is limited evidence on which injury, treatment and sociodemographic factors predict functional outcomes after ankle fracture in older adults. Previous studies have used small cohorts and few predictive factors.[@R3]

Rationale {#s1b}
---------

A multicentre randomised clinical trial of close contact casting versus surgery included 620 people aged 60 years and over with an unstable ankle fracture and found equivalence in outcomes between the treatment groups.[@R6] Irrespective of the initial fracture treatment, considerable outcome variation was evident in the trial cohort, highlighting the value of investigating which combination of socio-demographic and clinical prognostic factors could predict functional outcomes in this patient group. A prognostic model could inform patient counselling about prognosis and identify people who might benefit from additional monitoring or rehabilitation.

Objectives {#s1c}
----------

Develop and internally validate a prognostic model to predict (1) patient-reported and (2) objectively measured functional outcome 6 months after ankle fracture in people aged 60 years or over using sociodemographic and clinical data collected in the acute phase and at 6-week follow-up.

Methods {#s2}
=======

Study design and setting {#s2a}
------------------------

Data from the Ankle Injury Management (AIM) trial cohort (registration: ISRCTN04180738) were used to develop and internally validate prognostic models. AIM was a pragmatic, multicentre, randomised equivalence trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in people aged over 60 years. The trial methods and results have been published elsewhere.[@R6] Participants were recruited from May 2004 in a pilot centre, then from 24 centres (general hospitals and major trauma centres) in the UK from July 2010 to November 2013. The primary endpoint was 6 month follow-up. All participants gave written informed consent for data to be used.

Participants {#s2b}
------------

Eligible participants were aged 60 years or over and had an acute, overtly unstable ankle fracture (displaced or clinically unstable). Participants with insulin-dependent diabetes mellitus, active leg ulceration, critical limb ischaemia, open fracture, serious concomitant disease, substantial cognitive impairment or ankle arthritis, or who were not fit for anaesthesia, were excluded. Participants were allocated to usual care (open reduction and internal fixation surgery) or a minimally padded close contact cast. Both treatments were conducted under anaesthesia by an orthopaedic surgeon.

Outcome measures {#s2c}
----------------

### Primary outcome {#s2c1}

The primary outcome to be predicted was ankle function, measured using the Olerud and Molander Ankle Score (OMAS)[@R8] 6 months after fracture. The OMAS is a widely used questionnaire to assess outcomes after ankle fracture, covering a range of symptoms and mobility limitations. It is measured on a 0--100 scale, with lower scores representing worse ankle function. Participants reported their OMAS at follow-up clinics or, if unable to attend, over the telephone. If the participant did not have sufficient dexterity to complete the questionnaire independently the researcher acted as scribe.

### Secondary outcome {#s2c2}

The secondary outcome to be predicted was the Timed Up and Go (TUG) test,[@R9] an objective measurement of mobility conducted by a blinded outcome assessor. Participants were timed standing up from a chair, walking 8.6 m, turning and returning to sit in the start position. Participants' ankles had a dressing applied to obscure the presence of lack of surgical incision scars. The TUG test is responsive, valid and reliable assessment of mobility in older adults that has been shown to be predictive of falls risk and functional decline.[@R10]

Predictors {#s2d}
----------

Predictor variables were selected based on clinical rationale and availability in the clinical trial dataset ([table 1](#T1){ref-type="table"}). Two models were produced for each outcome to investigate whether predictor variables collected at 6-week follow-up clinics improved the baseline prediction. Predictor measurements were obtained from participant questionnaires or clinical assessments. Two experienced orthopaedic surgeons with no access to the clinical data assessed fracture misalignment at 6 weeks on anteroposterior or mortise and lateral radiographs.

###### 

Preselected predictors at baseline

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                   Measurement
  ------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------
  Baseline predictors                              

  Age                                              Years

  Sex                                              Male, female

  Treatment received                               Close contact cast/internal fixation surgery/other procedure

  Fracture classification                          Trans-infra-syndesmotic (Weber A and B), supra-syndesmotic (Weber C)

  Health status                                    Excellent, Very good, Good, Fair, Poor

  Smoking status                                   Never, Ex-smoker, Yes

  Admitted from                                    Own home, warden accommodation, acute hospital, community hospital, temporary residence

  Home support                                     Lives alone, lives with someone, lives with carer, home care package

  Alcohol status                                   Units per week

  Cognitive function:\                             Score (0--30, higher scores indicate better cognitive function)
  Mini-Mental State Examination (MMSE)             

  Number of comorbidities                          ≥0

  Walking distance preinjury                       About house, less than 100 m, less than 0.5 mile, more than 0.5 mile

  Walking aid preinjury                            None, one stick, two sticks, frame/rollator, wheelchair

  Preinjury ankle function:\                       Score (0--100, higher score indicates better ankle function)
  Preinjury OMAS (recall of preinjury status)      

  Health-related quality of life (HRQL):\          EQ-5D-3L score (upper bound equal to one indicates full health, 0 represents death, negative scores indicate a state worse than death)\
  EQ-5D-3L score at:\                              EQ-5D-3L VAS (0--100, higher scores indicate better HRQL)
  Day before injury\                               
  Postinjury (at baseline assessment)\             
  EQ-5D-3L visual analogue scale (VAS) at:\        
  Day before injury\                               
  Postinjury (at baseline assessment)              

  6-week follow-up predictors                      

  OMAS at 6 weeks                                  Score (0--100)

  EQ-5D-3L VAS 6 week                              As baseline

  EQ-5D-3L score at 6 weeks after injury           As baseline

  Injured ankle range of dorsiflexion              Hand-held goniometry, degrees

  Injured ankle range of plantar flexion           Hand-held goniometry, degrees

  Readmission to hospital                          Yes/No

  Started partial weight bearing by 6 weeks        Yes/No

  Radiological malalignment in 6 week radiograph   Yes/No
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Radiological malalignment at 6 weeks was assessed by a combination of bespoke measurement software and verification by two experienced consultant surgeon using the criteria: radiograph demonstrating any one or combination of showing talar subluxation \>2 mm (talar shift), excessive talar tilt (\>2°), or a diastasis (tibiofibular clear space ≥5 mm).

OMAS, Olerud and Molander Ankle Score.

Statistical analysis {#s2e}
--------------------

Sample size was constrained to the size of the AIM trial cohort as this was a pre-existing dataset. The number of variables was limited to those plausibly related the outcome. The OMAS and TUG multivariable models were built using data from 620 participants. We initially assessed the covariates by plotting scatter graphs of outcomes and each continuous covariate and comparing each covariate with another. If highly correlated predictors were found, only one was included in the multivariable modelling. Any predictors or participants with \>90% missing data were excluded. Remaining missing data were dealt with using single imputation before building the model.

As the outcomes were continuous, the prognostic models were developed under a linear regression modelling framework. The predictors ([table 1](#T1){ref-type="table"}) were included as independent variables in the model. Backwards elimination was performed to derive the models using the Akaike information criterion (AIC).

Categorical variables were collapsed into binary variables to ensure sufficient data points in each subcategory. The use of an assistive device for walking before injury was collapsed into whether the patient used assistance (yes: one stick, two sticks, frame/rollator, or wheelchair) or not (no). Walking distance before injury was split into \<0.5 miles and \>0.5 miles, reflecting the person's walking endurance. Home support was split into lives alone/with someone or lives with carer/has external care support. Continuous variables were investigated for non-linearity with the outcome using multivariable fractional polynomials.

Clinically plausible interactions were examined for inclusion in the model. Model performance was assessed by calculating the adjusted R^2^.

The prognostic models were internally validated through bootstrapping using 200 bootstrap samples (replaying all variable selection procedures) to correct for optimism and quantify and adjust the model for overfitting.[@R13] All analyses were conducted using Stata V.14.2. We followed the TRIPOD statement when reporting this study.[@R14]

Patient and public involvement {#s2f}
------------------------------

Patient and public involvement (PPI) representatives provided feedback on the research proposal in the planning stages of this study. A PPI representative was an independent member of the AIM trial steering committee.

Results {#s3}
=======

Participants {#s3a}
------------

The dataset contained 620 participants. Participants were aged median 70 (IQR 65--76) years and 459/618 (74%) were female. [Tables 2 and 3](#T2 T3){ref-type="table"} list the participant characteristics considered for building the models, the median (IQR) values for continuous variables, and the median OMAS and TUG values for categorical variables.

###### 

Median (IQR) values for the baseline and 6 week continuous variables and the 6-month outcomes

  Continuous variable                          n     Median (IQR)
  -------------------------------------------- ----- --------------------
  6-month OMAS score                           592   70 (50--80)
  6-month TUG                                  550   18 (14--23)
  Age (years)                                  618   70 (65--76)
  Mini Mental State Examination (MMSE)         556   29 (27--30)
  Number of alcohol units consumed in a week   614   2 (0--10)
  EQ-5D-3L VAS                                 557   85 (75--95)
  EQ-5D-3L VAS postinjury                      521   58 (40--75)
  Number of comorbidities                      618   1 (1--2)
  Preinjury OMAS                               618   100 (80--100)
  EQ-5D-3L score                               557   1 (0.80--1)
  EQ-5D-3L score postinjury                    522   0.02 (−0.06--0.16)
  Injured ankle range dorsiflexion             578   5 (0--10)
  Injured ankle range plantar flexion          578   20 (12--30)
  6-week OMAS                                  605   35 (30--50)
  6-week EQ-5D-3L score                        550   0.52 (0.31--0.71)
  6-week EQ-5D-3L VAS                          550   75 (60--86)

OMAS, Olerud and Molander Ankle Score; TUG, Timed Up and Go; VAS, visual analogue scale.

###### 

OMAS and TUG median (IQR) for baseline and 6-week categorical variables

  Categorical variable             n     Median OMAS (IQR)   n     Median TUG (IQR)
  -------------------------------- ----- ------------------- ----- ------------------
  Sex                                                              
  Male                             151   75 (60--90)         142   17 (14--19)
  Female                           441   65 (48--80)         408   18 (15--24)
  Smoking status                                                   
  Current smoker                   55    65 (50--80)         51    18 (14--23)
  Ex-smoker                        234   68 (50--80)         216   18 (14--23)
  Never                            303   70 (50--80)         283   18 (14--23)
  Health status                                                    
  Excellent                        135   75 (60--85)         132   15 (13--19)
  Very good                        250   70 (55--85)         233   18 (14--21)
  Good                             153   60 (45--80)         142   20 (16--27)
  Fair                             50    53 (35--70)         41    24 (18--33)
  Poor                             4     48 (11--88)         2     44 (28--59)
  Admitted from                                                    
  Own home                         576   70 (50--80)         539   18 (14--23)
  Warden accommodation             6     68 (41--86)         4     18 (17--25)
  Acute hospital                   2     55 (40--70)         2     29 (18--40)
  Community hospital               2     75 (70--80)         1     14 (14--14)
  Temporary residence              6     75 (59--91)         4     14 (12--20)
  Home support                                                     
  Lives alone                      188   70 (50--85)         173   19 (15--24)
  Lives with someone               398   70 (50--80)         375   17 (14--22)
  Lives with carer                 1     35 (35--35)         1     34 (34--34)
  Home care package                5     40 (25--55)         1     15 (15--15)
  Walking aid preinjury                                            
  None                             512   70 (55--85)         491   17 (14--21)
  One stick                        58    45 (35--61)         50    26(21--32)
  Two sticks                       6     48 (30--65)         4     37 (18--59)
  Frame/rollator                   13    40 (25--70)         4     88 (40--192)
  Wheelchair                       3     70 (45--95)         1     46 (46--46)
  Walking distance preinjury                                       
  About house                      17    55 (35--70)         6     29 (26--112)
  Less than 100 m                  33    40 (28--58)         28    37 (27--47)
  Less than 0.5 mile               58    55 (40--75)         52    22 (17--28)
  More than 0.5 mile               484   70 (55--85)         464   17 (14--21)
  Fracture pattern                                                 
  Weber A and B                    516   70 (50--80)         480   18 (14--23)
  Weber C                          76    65 (45--79)         70    18 (15--23)
  Treatment received                                               
  Close contact casting            271   70 (50--80)         246   18 (15--23)
  Internal fixation surgery        308   70 (55--80)         292   17 (14--22)
  Other                            13    55 (38--85)         12    20 (17--29)
  Readmission                                                      
  No                               542   70 (50--80)         506   18 (14--23)
  Yes                              50    63 (50--75)         44    18 (14--21)
  Started partial weight bearing                                   
  No                               224   70 (50--85)         213   17 (14--22)
  Yes                              368   70 (50--80)         337   18 (14--23)
  Radiological malalignment                                        
  No                               365   70 (50--80)         343   18 (14--23)
  Yes                              227   65 (45--80)         207   18 (15--23)

OMAS, Olerud and Molander Ankle Score; TUG, Timed Up and Go.

Missing data {#s3b}
------------

Two participants had \>90% missing data and were omitted from the analysis. Most predictors did not exceed 16% missing data. Most missing data occurred in the baseline EQ-5D-3L postinjury score. There were complete baseline, 6-week and outcome (OMAS and TUG) data for 434/620 (70%) participants.

Predicting patient-reported functional outcome 6 months after ankle fracture {#s3c}
----------------------------------------------------------------------------

### OMAS baseline model {#s3c1}

[Table 4](#T4){ref-type="table"} shows the eight baseline variables associated with 6 month OMAS and selected for the OMAS baseline model: preinjury OMAS, alcohol consumed per week (units), postinjury EQ-5D-3L visual analogue scale (VAS), sex, walking distance, walking aid, smoking status and health status. For instance, if all variables were kept constant, the 6-month OMAS for women was on average approximately 7 points lower than for equivalent men (p\<0.001, 6-month OMAS median (IQR), 70 (50--80)). A 10-point difference in the preinjury OMAS for two identical individuals led to an average difference of approximately 2 points in the 6-month OMAS. The units of alcohol consumed in a week and the postinjury EQ-5D-3L VAS had marginal (p=0.043) and non-influential (p=0.102) effects on the 6-month OMAS, respectively. People who could walk further than 0.5 miles before injury had an approximately 8-point higher OMAS than those who could not, and people who required a walking aid before injury were more likely to have an approximately 8-point lower OMAS.

###### 

Univariable analysis and the final baseline and baseline plus 6-week follow-up linear multivariable models for the 6 month OMAS score

  Variable                                         Univariable analysis         Final multivariable baseline model   Final multivariable baseline plus 6-week follow-up model                                      
  ------------------------------------------------ ---------------------------- ------------------------------------ ---------------------------------------------------------- --------- ------------------------ ---------
  Baseline                                                                                                                                                                                                         
   Constant                                                                                                          44.34 (30.04 to 58.64)                                     \<0.001   34.62 (20.00 to 49.23)   \<0.001
   Preinjury OMAS score                            0.48 (0.39 to 0.57)          \<0.001                              0.22 (0.09 to 0.34)                                        0.001     0.19 (0.07 to 0.31)      0.002
   Alcohol consumed per week (units)               0.34 (0.16 to 0.52)          \<0.001                              0.14 (−0.03, 0.32)                                         0.102     0.23 (0.07 to 0.40)      0.007
   EQ-5D-3L VAS Score (postinjury)                 0.18 (0.10 to 0.25)          \<0.001                              0.08 (0.003 to 0.15)                                       0.043                              
   Sex                                                                          \<0.001                                                                                         \<0.001                            0.010
   Female                                          −8.94 (--12.82 to 5.05)                                           −6.90 (−10.75 to 3.06)                                               −4.99 (−8.79 to 1.19)    
   Walking distance[\*](#tblfn5){ref-type="fn"}                                 \<0.001                                                                                         0.002                              0.015
   \>0.5 mile                                      19.10 (15.01 to 23.19)                                            7.79 (2.97 to 12.61)                                                 5.90 (1.16 to 10.64)     
   Walking aid                                                                  \<0.001                                                                                         0.003                              0.006
   Yes                                             −20.31 (--24.95, to 15.66)                                        −8.35 (−13.89, to 2.82)                                              −7.60 (13.01 to 2.20)    
   Smoking status[†](#tblfn6){ref-type="fn"}                                    0.185                                                                                           0.049                              0.061
   Ex-smoker                                       −1.57 (−7.87, 4.72)                                               −3.31 (−8.93, 2.30)                                                  −3.26 (−8.73, 2.20)      
   Never                                           1.83 (−4.33, 8.00)                                                0.85 (−4.69, 6.38)                                                   0.62 (−4.76, 6.00)       
   Health status[‡](#tblfn7){ref-type="fn"}                                     \<0.001                                                                                         0.023                              0.050
   Very good                                       −4.19 (−8.50, 0.13)                                               −1.79 (−5.82, 2.24)                                                  −2.25 (−6.17, 1.66)      
   Good                                            −13.42 (−18.13 to 8.70)                                           −6.90, (−11.48 to 2.32)                                              −6.50 (−10.93 to 2.07)   
   Fair                                            −20.69 (−27.41 to 13.97)                                          −2.97 (−10.32, 4.38)                                                 −4.48 (−11.51, 2.56)     
   Poor                                            −23.48 (−44.30to 2.66)                                            5.94 (−14.25, 26.14)                                                 2.95 (−16.61, 22.51)     
   Patient age                                     −0.54 (−0.77 to 0.31)        \<0.001                                                                                                                            
   MMSE                                            1.21 (0.43 to 2.00)          0.003                                                                                                                              
   EQ-5D-3L VAS Score (day before injury)          0.35 (0.25 to 0.46)          \<0.001                                                                                                                            
   EQ-5D-3L score (day before injury)              32.3 (23.07 to 41.53)        \<0.001                                                                                                                            
   EQ-5D-3L score (postinjury)                     11.24 (4.65 to 17.83)        \<0.001                                                                                                                            
   Number of comorbidities                         −3.58 (−4.89 to 2.28)        \<0.001                                                                                                                            
   Fracture pattern                                                             0.175                                                                                                                              
   Weber C                                         −3.59 (−8.78, 1.60)                                                                                                                                             
   Admitted from[§](#tblfn8){ref-type="fn"}                                     0.441                                                                                                                              
   Warden accommodation                            −8.31 (−23.57, 6.96)                                                                                                                                            
   Acute hospital                                  −10.01 (−40.38, 20.37)                                                                                                                                          
   Community hospital                              9.99 (−20.38, 40.37)                                                                                                                                            
   Temporary residence                             10.96 (−5.35, 27.26)                                                                                                                                            
   Treatment received[¶](#tblfn9){ref-type="fn"}                                0.249                                                                                                                              
   ORIF                                            1.67 (−1.83, 5.18)                                                                                                                                              
   Other                                           −6.33 (−16.75, 4.09)                                                                                                                                            
   Home support [\*\*](#tblfn10){ref-type="fn"}                                 0.003                                                                                                                              
   Live alone or with someone                      26.11 (8.63 to 43.59)                                                                                                                                           
  Additional 6 week variables                                                                                                                                                                                      
   6 week EQ-5D-3L VAS                             0.32 (0.21 to 0.42)          \<0.001                                                                                                                            
   Readmission to hospital                                                                                                                                                                                         
   Yes                                             −3.30 (−9.49, 2.89)          0.295                                                                                                                              
   Started partial weight bearing                                               0.575                                                                                                                              
   Yes                                             −1.01 (−4.54, 2.52)                                                                                                                                             
   Radiological malalignment present                                            0.124                                                                                                                              0.025
   Yes                                             −2.78 (−6.33, 0.77)                                                                                                                    −3.54 (−6.62 to 0.45)    
   Range of injured ankle motion Dorsiflexion      0.15 (−0.04, 0.34)           0.131                                                                                                     0.18 (0.007 to 0.35)     0.041
   Range of injured ankle motion Plantar flexion   0.14 (0.01 to 0.28)          0.032                                                                                                     0.17 (0.05 to 0.28)      0.006
   6 week OMAS                                     0.33 (0.22 to 0.44)          \<0.001                                                                                                   0.19 (0.09 to 0.30)      \<0.001
   6 week EQ-5D-3L score                           25.69 (18.66 to 32.72)       \<0.001                                                                                                   10.21 (3.64 to 16.78)    0.002

\*Reference category for walking distance is '\<0.5 mile'.

†Reference category for smoking status is 'Current smoker'.

‡Reference category for health status is 'Excellent'.

§Reference category for admitted from is 'Own home'.

¶Reference category for treatment received is 'CCC'.

\*\*Reference category for home support is 'live with care or has external care support'.

NB, EQ-5D-3L VAS Score (postinjury) omitted from final model by backward selection and correlation with 6-week score.

MMSE, Mini-Mental State Examination; OMAS, Olerud and Molander Ankle Scale; ORIF, Open Reduction and Internal Fixation; VAS, Visual Analogue Scale.

The initial model containing all candidate predictors had an R^2^ value of 0.25. The final model had an R^2^ value of 0.238 and an adjusted R^2^ of 0.223: the model's predictors explained approximately 22% of the outcome variation.

### OMAS baseline model internal validation {#s3c2}

After bootstrapping, the optimism-corrected R^2^ performance estimate was 0.228. The model's performance on the internal validation was similar to that achieved on the original dataset, indicating no evidence for any overfitting.

### OMAS baseline/6-week model {#s3c3}

Adding the 6-week follow-up variables produced a model similar to the baseline model, minus postinjury EQ-5D-3L VAS, plus five 6-week follow-up variables: presence of radiological malalignment, range of motion in the injured ankle for dorsiflexion and plantar flexion, 6-week OMAS and 6-week EQ-5D-3L ([table 4](#T4){ref-type="table"}). A patient with radiological malalignment at 6 weeks would, on average, have a 6-month OMAS approximately 4 points lower than a patient without malalignment. Keeping all other variables constant, 20° more ankle motion in both dorsiflexion and plantar flexion at 6 weeks would result in an approximately 4-point higher 6-month OMAS. The higher the 6-week OMAS and EQ-5D-3L, the greater the 6-month OMAS (p\<0.001 and p=0.002, respectively).

The baseline/6-week model had an adjusted R^2^ value of 0.261 which was higher than the baseline model's adjusted R^2^. Including the 6-week follow-up variables explained around 4% more variation than the baseline model.

### OMAS baseline/6-week model internal validation {#s3c4}

After bootstrapping, the optimism-corrected R^2^ performance estimate was 0.264, similar to that on the original dataset. Approximately 26% of the variation in the 6 month OMAS was explained by the model, an increase of 3% from the baseline linear multivariable model.

In an exploratory analysis, a model using only the 6-week variables was developed. The adjusted R^2^ value was 0.123, which was significantly lower than the model performance for the baseline model.

Predicting objectively measured functional outcome 6 months after ankle fracture {#s3d}
--------------------------------------------------------------------------------

### TUG baseline model {#s3d1}

[Table 5](#T5){ref-type="table"} shows the baseline variables associated with the TUG time at 6 months and included in the baseline TUG model. On average women had around 6 s (p\<0.001) longer TUG times than men (6-month TUG median (IQR), 18 s (14 to23)). Holding all other variables constant, a 10-point increase in the mini-mental state examination score led to a 2 s decrease in the predicted TUG time (p\<0.001). A 10-year age difference between two otherwise identical individuals resulted in an 8 s longer predicted TUG time for the older individual (p\<0.001). Those with higher postinjury EQ-5D-3L VAS were more likely to have a quicker TUG time at 6 months (p\<0.001). People able to walk further than 0.5 mile before injury had a TUG time approximately 20 s quicker than an equivalent person who could only walk less than 0.5 mile (p\<0.001). People who required a walking aid before injury were 19 s slower, on average, than those who did not. Fracture pattern and preinjury OMAS predicted the TUG score well: a Weber C fracture pattern and low preinjury OMAS predicted a longer TUG time.

###### 

Univariable analysis and the final baseline and baseline plus 6-week follow-up linear multivariable models for the 6month TUG score

  Variable                                          Univariable analysis       Final multivariable baseline model   Final multivariable baseline plus 6-week follow-up model                                       
  ------------------------------------------------- -------------------------- ------------------------------------ ---------------------------------------------------------- --------- ------------------------- ---------
  Baseline                                                                                                                                                                                                         
   Constant                                                                                                         24.86 (−0.31, 50.03)                                       0.05      51.72 (29.34 to 74.11)    \<0.001
   Preinjury OMAS score                             −0.38 (−0.45 to 0.30)      \<0.001                              −0.09 (−0.19, 0.0007)                                      0.05                                
   Alcohol consumed per week (units)                −0.24 (−0.38 to 0.10)      0.001                                                                                                                               
   EQ-5D-3L VAS Score (postinjury)                  −0.12 (−0.18 to 0.06)      \<0.001                              −0.05 (−0.10, 0.006)                                       0.08                                
   Sex                                                                         \<0.001                                                                                         0.008                               0.02
   Female                                           5.64 (2.51 to 8.78)                                             3.61 (0.93 to 6.29)                                                  3.30 (0.57 to 6.03)       
   Walking distance[\*](#tblfn13){ref-type="fn"}                               \<0.001                                                                                         \<0.001                             \<0.001
   \>0.5 mile                                       −19.67 (−22.80 to 16.53)                                        −12.26 (−15.87 to 8.65)                                              −9.90 (−13.30 to 6.50)    
   Walking aid                                                                 \<0.001                                                                                         0.001                               \<0.001
   Yes                                              19.00 (15.35 to 22.64)                                          7.67 (3.34 to 11.99)                                                 6.10 (2.35 to 9.85)       
   Smoking status[†](#tblfn14){ref-type="fn"}                                  0.33                                                                                                                                0.04
   Ex-smoker                                        −0.06 (−5.11, 4.99)                                                                                                                  −1.26 (−5.48, 2.96)       
   Never                                            −2.15 (−7.10, 2.81)                                                                                                                  −3.93 (−8.07, 0.21)       
   Health status[‡](#tblfn15){ref-type="fn"}                                   \<0.001                                                                                                                             
   Very good                                        1.62 (−1.84, 5.07)                                                                                                                                             
   Good                                             7.68 (3.90 to 11.46)                                                                                                                                           
   Fair                                             18.08 (12.70 to 23.47)                                                                                                                                         
   Poor                                             23.27 (6.60 to 39.94)                                                                                                                                          
   Patient age                                      0.79 (0.61 to 0.97)        \<0.001                              0.36 (0.18 to 0.54)                                        \<0.001   0.37 (0.20 to 0.54)       \<0.001
   MMSE                                             −2.15 (−2.75 to 1.54)      \<0.001                              −0.89 (−1.46 to 0.32)                                      0.002     −1.35 (−1.91 to 0.79)     \<0.001
   EQ-5D-3L VAS Score (day before injury)           −0.35 (−0.43 to 0.26)      \<0.001                                                                                                                             
   EQ-5D-3L score (day before injury)               −21.22 (−28.46 to 13.97)   \<0.001                              6.73 (−0.99, 14.44)                                        0.09                                
   EQ-5D-3L score (postinjury)                      −8.48 (−13.92 to 3.03)     0.002                                                                                                                               
   Number of comorbidities                          3.43 (2.34 to 4.46)        \<0.001                                                                                                                             
   Fracture pattern                                                            0.03                                                                                            0.03                                
   Weber C                                          4.61 (0.46 to 8.76)                                             3.97 (0.44 to 7.50)                                                                            
   Admitted from[§](#tblfn16){ref-type="fn"}                                   0.67                                                                                                                                
   Warden accommodation                             0.82 (−11.44, 13.07)                                                                                                                                           
   Acute hospital                                   6.72 (−17.66, 31.11)                                                                                                                                           
   Community hospital                               −0.50 (−24.89, 23.89)                                                                                                                                          
   Temporary residence                              −9.53 (−22.62, 3.56)                                                                                                                                           
   Treatment received[¶](#tblfn17){ref-type="fn"}                              0.35                                                                                                                                
   ORIF                                             −0.94 (−3.75, 1.87)                                                                                                                                            
   Other                                            4.95 (−3.41, 13.31)                                                                                                                                            
   Home support[\*\*](#tblfn18){ref-type="fn"}                                 0.03                                                                                                                                
   Live alone or with someone                       −15.40 (−29.47 to 1.34)                                                                                                                                        
  Additional 6 week variables                                                                                                                                                                                      
   6-week EQ-5D-3L VAS                              −0.24 (−0.32 to 0.16)      \<0.001                                                                                                   −0.07 (−0.14, 0.00)       0.05
   Readmission to hospital                                                     0.06                                                                                                                                0.03
   Yes                                              −4.83 (−9.81, 0.15)                                                                                                                  −4.49 (−8.60 to 0.38)     
   Started partial weight bearing                                              0.96                                                                                                                                
   Yes                                              0.08 (−2.77, 2.92)                                                                                                                                             
   Radiological malalignment present                                           0.24                                                                                                                                
   Yes                                              −1.73 (−4.59 1.13)                                                                                                                                             
   Range of injured ankle motion dorsiflexion       −0.005 (−0.16, 0.15)       0.95                                                                                                                                
   Range of injured ankle motion plantar flexion    0.01 (−0.09, 0.12)         0.83                                                                                                                                
   6-week OMAS                                      −0.13 (−0.22 to 0.04)      0.005                                                                                                                               
   6-week EQ-5D-3L score                            −23.76 (−29.46 to 18.06)   \<0.001                                                                                                   −11.11 (−16.13 to 6.09)   \<0.001

\*Reference category for walking distance is '\<0.5 mile'.

†Reference category for smoking status is 'Current smoker'.

‡Reference category for health status is 'Excellent'.

§Reference category for admitted from is 'Own home'.

¶Reference category for treatment received from is 'CCC'.

\*\*Reference category for home support is 'live with care or has external care support'.

NB, EQ-5D-3L VAS Score (postinjury) omitted from final model by backward selection and correlation with 6-week score.

MMSE, Mini-Mental State Examination; OMAS, Olerud and Molander Ankle Scale; ORIF, Open Reduction and Internal Fixation; VAS, Visual Analogue Scale

The initial model containing all possible variables had an R^2^ value of 0.321, indicating that all of the variables chosen for consideration in model building together explained 32% of the variation in the TUG outcome. The final baseline model had an R^2^ value of 0.308 and an adjusted R^2^ of 0.298, indicating that the model's predictors explained approximately 30% of the outcome variation.

### TUG baseline model internal validation {#s3d2}

After bootstrapping, the optimism-corrected R^2^ performance estimate was 0.293. The model's performance on the internal validation was very similar to that achieved on the original dataset, explaining approximately 30% of the variation in the 6 month TUG score.

### TUG baseline/6-week model {#s3d3}

When the 6-week variables were included in building a model to predict the 6-month TUG time, four baseline variables were removed. The model-building process selected another baseline variable, home support, for inclusion in their place. Its inclusion led to spurious results as there were little data in one of the subcategories (lives with carer/has external care support). The variable was therefore removed from the final model. The final model also included three 6-week variables: readmission, 6-week EQ-5D-3L and 6-week EQ-5D-3L VAS ([table 5](#T5){ref-type="table"}).

If a person was readmitted in the first 6 weeks after injury, they were predicted to have a 4 s faster TUG time at 6 months (p=0.04), if all other variables were held constant. Those with a better EQ-5D-3L score at 6 weeks were more likely to have a quicker TUG (p\<0.001). If all other variables were kept constant, an increase of 20 points in the 6-week VAS resulted in a 1.5 s quicker time (p=0.04).

The baseline/6-week data model had a greater adjusted R^2^ (0.321) than the baseline data model (0.308). The model now explained 32% of the variability in TUG at 6 months, 2% more than that explained by the baseline data model.

### TUG baseline/6-week model internal validation {#s3d4}

After bootstrapping, optimism-corrected R^2^ performance estimate was 0.314. The model's performance on the internal validation dataset was very similar to that achieved on the original dataset, explaining approximately 31% of the variation in the 6 month TUG time.

In an exploratory analysis, a model using only the 6 week variables was developed. The adjusted R^2^ value was 0.109, which was lower than the model performance for the baseline model.

Sensitivity analysis {#s3e}
--------------------

By using single imputation for the missing values in the 6-month OMAS and TUG outcomes, we assumed that the missing values occurred at random, so that variables in the dataset could predict the occurrence of missing values. To check how sensitive the four models were to this assumption, we conducted a complete-case analysis, which assumes that missing values occur completely at random.

Twenty-six participants were omitted from the OMAS models, leaving 592 participants. The same variables were selected for the baseline data model. The same variables were selected for the baseline/6 week data model, plus postinjury EQ5D-3L VAS and 'started partial weight bearing'. Both models had marginally lower adjusted R^2^ values: 0.205 for the baseline data model, 2% lower than the original model, and 0.256 for the baseline/6-week data model, 0.5% lower than the original model. After bootstrapping, the optimism-corrected R^2^ performance estimates of 0.215 for the baseline data model and 0.268 for the baseline/6-week data model.

Sixty-eight participants were omitted from the TUG models, leaving 550 participants. The baseline data model included the same variables as before, but replaced baseline postinjury EQ-5D-3L VAS with baseline recall preinjury EQ-5D-3L VAS and omitted preinjury OMAS. The baseline/6-week data model included the same variables as before, plus fracture pattern and walking aid. Both models had lower adjusted R^2^ values: 0.222 for the baseline data model, 8% lower than the original model, and 0.264 for the baseline/6-week data model, 6% lower than the original model. After bootstrapping, the optimism-corrected R^2^ performance estimates were 0.215 for the baseline data model and 0.253 for the baseline/6-week data model.

Discussion {#s4}
==========

A prognostic model has the potential to inform anticipated recovery, and identify people who may benefit from additional monitoring or rehabilitation. We developed and internally validated four prognostic models for 6-month outcomes after ankle fracture using recommended methods[@R13] and a wide range of regularly collected data on plausible prognostic factors from hospital admission and at 6 week follow-up clinics. The OMAS baseline data model included: alcohol per week (units), postinjury EQ-5D-3L VAS, sex, preinjury walking distance and walking aid use, smoking status and perceived health status. The baseline/6-week data model included the same baseline variables, minus EQ-5D-3L VAS, plus five 6-week predictors: radiological malalignment, injured ankle dorsiflexion and plantarflexion range of motion and 6-week OMAS and EQ-5D-3L. The models explained approximately 23% and 26% of the outcome variation, respectively. Similar baseline and baseline/6-week data models to predict TUG explained around 30% and 32% of the outcome variation, respectively. Adding 6-week follow-up variables to baseline variables provided only a modest benefit. This benefit arguably does not outweigh the logistical issues of obtaining patient information at 6 weeks to improve prediction accuracy. The models performed similarly on the development dataset and bootstrapped internal validation datasets.

Predictive accuracy of the four models using commonly recorded clinical data to predict self-reported or objectively measured ankle function 6 months after unstable ankle fracture in adults aged over 60 years was relatively low. As there are limitations in predictive performance, we do not recommend using these prognostic models in clinical practice as decision-making tools in isolation.

The variables of most predictive value across the prognostic models were sex, with females having worse outcomes than males. A cohort of 584 severe ankle sprain participants also found that females had worse outcomes.[@R15] Self-reported preinjury walking distance and preinjury walking aid use was also predictive of outcome, with those able to walk less than 0.5 miles doing and using a walking aid faring worse than those able to walk further and not needing aids. These factors are features of declining locomotor function and are likely to be related to a greater levels of frailty preinjury.[@R16]

The inferences presented here cannot be extended to propose causal relationships between the predictors and outcomes, as we did not consider issues such as confounding. As the aim and design of this study prioritised optimising prognostic accuracy, predictors were considered without considering whether they could form a causal pathway or not.[@R17]

Comparisons with other studies that have developed prognostic models for people after ankle fracture are challenging as, to the best of our knowledge, this is the first study to focus on older adults, use a larger cohort, and internally validate the developed models to adjust for optimism. A two-centre observational study of 60 adults (mean age 49) reported that ankle dorsiflexion and fracture classification (number of malleoli injured) predicted OMAS 6 months after cast removal (R^2^=0.4).[@R3] In a larger cohort of 150 adults (mean age 46), Lin and colleagues[@R7] developed a model to predict patient-reported lower limb function (Lower Extremity Functional Scale)[@R18] at 4 and 12 weeks after cast removal. The models were not internally validated, but were externally validated in a separate cohort of 94 participants. Eight predictors were examined. Pain and dorsiflexion after cast removal were included in the final model, which explained about 15% of the outcome variability in the development stage and even less in the external validation.

The lack of predictive power of both our models and those in the literature indicate that functional outcomes after ankle fracture may be difficult to predict, or other prognostic factors may need to be considered to improve predictions of functional outcome. Our models may be missing informative predictors that were not captured in the AIM trial dataset. More detailed injury characteristics, such as whether fractures were uni-malleolar, bi-malleolar or tri-malleolar, were not explored. The extent of articular damage assessed by specialist imaging could provide useful prognostic information. However, any techniques using specialist equipment or personnel would hamper clinical utility for routine use and would be difficult to implement if there were resource implications. Further research is recommended to investigate whether a wider range of psychosocial and environmental factors[@R19] can enhance predictive accuracy. There is preliminary evidence that catastrophising and fear avoidance are potential psychological prognostic factors that warrant further investigation in people after ankle fracture.[@R20]

Similar results were found for the main and sensitivity analyses of both the OMAS and TUG models. The assumption that data were missing at random was therefore plausible and conducting single imputation before model building was probably appropriate.

This study was limited by the use of an existing clinical trial dataset for developing the prognostic model, as the choice of potential prognostic factors were restricted to those collected in the trial. Clinical trial cohorts are usually more selective than the wider clinical population. However, the AIM trial was a pragmatic study to enhance external validity. The use of a clinical trial cohort to develop prognostic models is also not uncommon, and has resulted in robust prognostic models for other ankle injury populations that have been successfully externally validated.[@R21] Strengths of using this clinical trial dataset were that it had very low levels of missing data and that it reflected data that are or could be routinely collected during acute hospital admission and clinic follow-up.

Conclusion {#s5}
==========

We developed and internally validated prognostic models to predict functional outcomes 6 months after unstable ankle fracture in older adults using commonly recorded clinical data. These prognostic models had relatively limited accuracy in predicting self-reported or objectively measured ankle function. Other potential predictors (eg, psychological factors such as catastrophising and fear avoidance) should be investigated.
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